P. Mulders

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report.

S. Aamdal, J. Wanders, A. Eggermont, 2003, European journal of cancer.

A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer

J. Rossi, N. James, U. Prabhakar, 2010, British Journal of Cancer.

Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.

C. Porta, A. Ravaud, V. Flamand, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients

C. Lamers, P. Mulders, E. Oosterwijk, 2004, British Journal of Cancer.

A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer

J. Rossi, U. Prabhakar, S. Négrier, 2010, British Journal of Cancer.

Novel treatment strategies in clear-cell metastatic renal cell carcinoma.

D. V. van Spronsen, P. Mulders, P. D. De Mulder, 2005, Anti-cancer drugs.

Current treatment of renal cell carcinoma.

P. Mulders, P. D. De Mulder, C. V. van Herpen, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN.

M. Gore, B. Melichar, V. Matveev, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

A prospective open-label single-arm phase II study of chimeric monoclonal antibody cG250 in advanced renal cell carcinoma patients.

C. Lamers, P. Mulders, P. D. De Mulder, 2003, Folia biologica.

Survival update from a multicenter, randomized, phase III trial of vitespen versus observation as adjuvant therapy for renal cell carcinoma in patients at high risk of recurrence.

B. Escudier, S. Gorelov, L. Isakov, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.